Meditate Temporary Implantable Nitinol Device

被引：3
|
作者：
Porpiglia F. [1 ]
Fiori C. [1 ]
Bertolo R. [1 ]
Amparore D. [1 ]
机构：
[1] Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin
来源：
Current Bladder Dysfunction Reports | 2017年 / 12卷 / 2期
关键词：
Benign prostatic hyperplasia (BPH); Lower urinary tract symptoms (LUTS); Micturition; Minimally invasive surgery; Sexual function; Temporary implantable nitinol device (TIND);
D O I：
10.1007/s11884-017-0424-5
中图分类号：
学科分类号：
摘要：
Purpose of the Review: The purpose of the review was to evaluate the available literature concerning a novel minimally invasive temporary implantable nitinol device (TIND) for the treatment of benign prostatic hyperplasia (BPH), named MEDITATE (Medi-Tate®; Medi-Tate Ltd., Or Akiva, Israel). Recent Findings: A novel technique based on an innovative device was presented being temporary implantable. Clinical experiences with MEDITATE TIND have been started. Up-to-date promising outcomes are reported. Summary: TIND can be a viable minimally invasive surgical approach in the treatment of lower urinary tract symptoms correlated to benign prostate hyperplasia. Best candidates are patients who are unfit for major surgeries, patients who are refractory to standard medical treatment and patients who would like to preserve ejaculation. © 2017, Springer Science+Business Media New York.
引用
收藏
页码：124 / 128
页数：4
相关论文
共 50 条
  • [1] MEDITATE® TEMPORARY IMPLANTABLE NITINOL DEVICE (TIND) IN THE TREATMENT OF BENIGN PROSTATIC OBSTRUCTION: TWO YEARS OF FOLLW-UP RESULTS.
    Fiori, Cristian
    Amparore, Daniele
    Checcucci, Enrico
    Ottaviano, Giulia
    De Cillis, Sabrina
    Di Stasio, Andrea
    Serra, Nicoletta
    Bertolo, Riccardo
    Cattaneo, Giovanni
    Porpiglia, Francesco
    JOURNAL OF UROLOGY, 2016, 195 (04): : E459 - E459
  • [2] Initial experience with Temporary Implantable Nitinol Device (TIND) for benign prostatic hyperplasia
    Ho, B.
    Wong, C.
    Tsang, C. F.
    Lai, T.
    Ng, A.
    Ma, W. K.
    Tsu, H. L.
    BJU INTERNATIONAL, 2019, 123 : 13 - 13
  • [3] THE NEW MEDITATE® TEMPORARY IMPLANTABLE NITINOL DEVICE (I-TIND) IN THE TREATMENT OF BLADDER OUTLET OBSTRUCTION DUE TO BPH: RESULTS OF ONE ARM, MULTI-CENTER PROSPECTIVE, STUDY
    Porpiglia, Francesco
    Fiori, Cristian
    Amparore, Daniele
    Manit, Arya
    Kadner, Gregor
    Valerio, Massimo
    Shulman, Claude
    JOURNAL OF UROLOGY, 2017, 197 (04): : E512 - E512
  • [4] THE RESULTS OF ONE ARM MULTICENTER PROSPECTIVE STUDY ON AN INNOVATIVE MINIMALLY INVASIVE SURGICAL TECHNIQUE FOR LUTS MANAGEMENT: THE SECOND GENERATION TEMPORARY IMPLANTABLE NITINOL DEVICE (I-TIND) MEDITATE®
    Porpiglia, Francesco
    Fiori, Cristian
    Amparore, Daniele
    Volpi, Gabriele
    Kadner, Gregor
    Manit, Arya
    Valerio, Massimo
    Nicolaas, Lumen
    Ho, Brian S. H.
    Alonso, Sergio
    Schulman, Claude
    Barber, Neil
    JOURNAL OF UROLOGY, 2019, 201 (04): : E2 - E2
  • [5] Follow-up of Temporary Implantable Nitinol Device (TIND) Implantation for the Treatment of BPH: a Systematic Review
    Bertolo, Riccardo
    Fiori, Cristian
    Amparore, Daniele
    Porpiglia, Francesco
    CURRENT UROLOGY REPORTS, 2018, 19 (06)
  • [6] Follow-up of Temporary Implantable Nitinol Device (TIND) Implantation for the Treatment of BPH: a Systematic Review
    Riccardo Bertolo
    Cristian Fiori
    Daniele Amparore
    Francesco Porpiglia
    Current Urology Reports, 2018, 19
  • [7] iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia
    Balakrishnan, Dhivya
    Jones, Patrick
    Somani, Bhaskar K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2020, 12
  • [8] 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction
    Porpiglia, Francesco
    Fiori, Cristian
    Bertolo, Riccardo
    Giordano, Andrea
    Checcucci, Enrico
    Garrou, Diletta
    Cattaneo, Giovanni
    De Luca, Stefano
    Amparore, Daniele
    BJU INTERNATIONAL, 2018, 122 (01) : 106 - 112
  • [9] THE TEMPORARY IMPLANTABLE NITINOL DEVICE (ITIND) FOR THE MINIMALLY INVASIVE TREATMENT OF BPH: COMPARISON OF 3-YEAR OUTCOMES & COST IN CANADA
    Elterman, D.
    Shepherd, S.
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S250 - S251
  • [10] THE TEMPORARY IMPLANTABLE NITINOL DEVICE (ITIND) FOR THE MINIMALLY INVASIVE TREATMENT OF BPH: COMPARISON OF 3-YEAR OUTCOMES & COST IN CANADA
    Elterman, Dean
    Shepherd, Shaun
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S662 - S663
12345